Back to User profile » Prof. Dr. Michael Lux
Paper published by Prof. Dr. Michael Lux:
Original Research
Can contemporary trials of chemotherapy for HER2-negative metastatic breast cancer detect overall survival benefit?
Kümmel S, Jackisch C, Müller V, Schneeweiss A, Klawitter S, Lux MP
Cancer Management and Research 2018, 10:5423-5431
Published Date: 8 November 2018